Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering ... (al trials for the diagnosis of Parkinson...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference

Date:5/5/2008

al trials for the diagnosis of Parkinsonian Syndromes including Parkinson's Disease. The Company has research collaborations with Harvard Medical School and Children's Hospital Boston.

Alseres is a trademark and CETHRIN and ALTROPANE are registered trademarks of Alseres Pharmaceuticals, Inc.

Contact: Sharon Correia -- 508-497-2360 ext 224 scorreia@alseres.com or

Adam Friedman -- 212-981-2529 ext 18 adam@adam-friedman.com

http://www.alseres.com

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
2. Alseres Pharmaceuticals, Inc. Raises $5 Million
3. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
4. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
5. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
6. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
7. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
8. Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development
9. Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement
10. Barr Pharmaceuticals, Inc. Executive Bios
11. Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation

Post Your Comments:

Breaking Medicine News(10 mins):Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2 Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2 Health News:Patriot Scientific Corporation Announces New Director 2 Health News:Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight' 2

[0] Wellness Manufacturer Wins Two 2009 American Spa Awards [0] Unanimous Vote Creates Largest RN Union in U.S. History [0] Patriot Scientific Corporation Announces New Director [1] Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight'[0] Nearly 3 Million Doses of H1N1 Vaccine Allocated to Pennsylvania since Start of Vaccination Effort

Other Medicine News:Health News:Torchmark Corporation Declares Dividend 2 Health News:America's Pending Shortage of Cancer Doctors 2 Health News:America's Pending Shortage of Cancer Doctors 3 Health News:Preeclampsia Might Protect Against Testicular Cancer 2 Health News:Preeclampsia Might Protect Against Testicular Cancer 3 Health News:New Online Support Site Offers Hope, Information, and Help for Patients Who Have Suffered a Catastrophic Injury 2 Health News:Media Affects Public Perception of Infectious Diseases 2 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 2 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 3 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 4 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 5 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 6 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 7 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 8 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 9 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 10 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 11 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 12 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 13 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 14 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 15 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 16 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 17 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 18 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 19 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 20 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 21 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 22 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 23 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 24 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 25 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 26 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 27 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 28 Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 29

Torchmark Corporation Declares Dividend America's Pending Shortage of Cancer Doctors Preeclampsia Might Protect Against Testicular Cancer New Online Support Site Offers Hope, Information, and Help for Patients Who Have Suffered a Catastrophic Injury Media Affects Public Perception of Infectious Diseases Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1):

Breaking Medicine Technology:ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2 ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3 ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4 VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7 Qforma Appoints Erin McLaughlin as Director Field Operations 5834 1 Qforma Appoints Erin McLaughlin as Director Field Operations 5834 2 Webcast Alert 3A Transgenomic Inc Announces Third Quarter 2009 Earnings Release Conference Call Webcast 5832 1 Webcast Alert 3A Transgenomic Inc Announces Third Quarter 2009 Earnings Release Conference Call Webcast 5832 2 High Resolution Breast PET Improves Breast Cancer Detection 5830 1 High Resolution Breast PET Improves Breast Cancer Detection 5830 2 High Resolution Breast PET Improves Breast Cancer Detection 5830 3

[0] ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program [0] VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation [0] Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology

Other Medicine Technology:Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms 2 Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms 3 New, Published GELNIQUE Data Show Efficacy, Convenience and Excellent Tolerability 2 New, Published GELNIQUE Data Show Efficacy, Convenience and Excellent Tolerability 3 New, Published GELNIQUE Data Show Efficacy, Convenience and Excellent Tolerability 4

Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms New, Published GELNIQUE Data Show Efficacy, Convenience and Excellent Tolerability

Medicine Products:

Hip Stabilizers The Impact Walker HighTide Diabetic MaxTrax Walker